Authors: Toseland, CDN Campbell, S Francis, I Bugelski, PJ Mehdi, N

Citation: Cdn. Toseland et al., Comparison of adipose tissue changes following administration of rosiglitazone in the dog and rat, DIABET OB M, 3(3), 2001, pp. 163-170

Authors: Smith, SA Lister, CA Toseland, CDN Buckingham, RE

Citation: Sa. Smith et al., Rosiglitazone prevents the onset of hyperglycaemia and proteinuria in the Zucker diabetic fatty rat, DIABET OB M, 2(6), 2000, pp. 363-372

Authors: Piercy, V Toseland, CDN Turner, NC

Citation: V. Piercy et al., Acceleration of the development of diabetes in obese diabetic (db/bd) miceby nicotinamide: A comparison with its antidiabetic effects in non-obese diabetic mice, METABOLISM, 49(12), 2000, pp. 1548-1554

Authors: Piercy, V Toseland, CDN Turner, NC

Citation: V. Piercy et al., Potential benefit of inhibitors of advanced glycation end products in the progression of type II diabetes: A study with aminoguanidine in C57/BLKsJ diabetic mice, METABOLISM, 47(12), 1998, pp. 1477-1480

Authors: Benson, GM Schiffelers, R Nicols, C Latcham, J Vidgeon-Hart, M Toseland, CDN Suckling, KE Groot, PHE

Citation: Gm. Benson et al., Effect of probucol on serum lipids, atherosclerosis and toxicology in fat-fed LDL receptor deficient mice, ATHEROSCLER, 141(2), 1998, pp. 237-247